Year-end Sale % OFF 
Abstract
Background: Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are associated with similar or lower rates of major bleeding (MB) compared to warfarin. However, few studies have evaluated the MB-related medical costs. This study compared risk of MB and MB-related medical costs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
